<DOC>
	<DOCNO>NCT02610036</DOCNO>
	<brief_summary>The purpose study assessment microangiopathy determine increase capillary basement membrane thickness decrease capillary lumen area foot ulcer 30 neuropathic 30 neuroischemic type 2 diabetic patient</brief_summary>
	<brief_title>Obliterating Diabetic Microangiopathy Diabetic Foot</brief_title>
	<detailed_description>Primary endpoint study quantitatively evaluate presence microangiopathy increase capillary basement membrane thickness decrease capillary lumen area determine transmission electron microscopy analysis type 2 diabetic patient motor-sensory neuropathy chronic critical ischemia affect foot ulcer . The following parameter evaluate : - presence capillary ( n/mm2 ) thrombosis ( % ) correlation quantitative histological data ischemic parameter ( TcPO2 , ankle-brachial index ) risk diastasis - correlation presence inflammatory infiltrate ( leukocytes/mm2 ) blood inflammatory parameter ( erythrocyte sedimentation rate ( ESR ) , C-reactive protein , alpha-2 globulin ) - rate diastasis and/or time require recovery associate histopathological data - presence acanthosis related clinical demographic variable</detailed_description>
	<mesh_term>Diabetic Foot</mesh_term>
	<criteria>adult type 2 diabetic patient either gender diabetes 10 year motorsensory diabetic neuropathy without chronic critical ischemia local resident ulcer surgical therapy indication removal 1st ray gangrene osteomyelitis type 1 diabetic patient diabetes less 10 year renal replacement therapy urgent surgical procedure sepsis immunosuppressive therapy local resident Cancer adverse prognosis month , chemotheraputic treatment Ongoing plan pregnancy Lack consent participate study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>diabetes</keyword>
	<keyword>foot ulcer</keyword>
</DOC>